Darbepoetin alfa shows safety and efficacy when dosed every 3 weeks. Comment

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)125
Number of pages1
JournalOncology Report
Issue numberFALL
StatePublished - Sep 2005

Fingerprint

Safety
Darbepoetin alfa

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Darbepoetin alfa shows safety and efficacy when dosed every 3 weeks. Comment. / Schwartzberg, Lee.

In: Oncology Report, No. FALL, 09.2005, p. 125.

Research output: Contribution to journalComment/debate

@article{34c4b682d1434aae91a97d5f8a3f093c,
title = "Darbepoetin alfa shows safety and efficacy when dosed every 3 weeks. Comment",
author = "Lee Schwartzberg",
year = "2005",
month = "9",
language = "English (US)",
pages = "125",
journal = "Oncology Report",
issn = "1548-5323",
publisher = "Elsevier BV",
number = "FALL",

}

TY - JOUR

T1 - Darbepoetin alfa shows safety and efficacy when dosed every 3 weeks. Comment

AU - Schwartzberg, Lee

PY - 2005/9

Y1 - 2005/9

UR - http://www.scopus.com/inward/record.url?scp=27144513749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144513749&partnerID=8YFLogxK

M3 - Comment/debate

SP - 125

JO - Oncology Report

JF - Oncology Report

SN - 1548-5323

IS - FALL

ER -